#1TRUFLOWER CENTRATES FSOTIONS Truliev R Third Quarter 2023 Investor Presentation / November 2023 CSE: TRUL OTCQX: TCNNF#2www.trulieve.com Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms "Trulieve," "we," "us" and "our" in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation (collectively herein referred to as "forward-looking statements"), which can often be identified by words such as "will", "may", "estimate", "expect", "plan", "project", "intend", "anticipate" and other words indicating that the statements are forward-looking. These forward-looking statements relate to Trulieve's expectations or forecasts of business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs and include statements regarding Trulieve's 2023 objectives for cash generation and preservation and investment, Trulieve's financial targets, and its plans for potential acquisitions and expansion of the Company's operations. Such forward-looking statements are expectations only and are subject to known and unknown risks, uncertainties and other important factors, including, but not limited to, risk factors included in this presentation, that could cause the Company's actual results, performance or achievements or industry results to differ materially from any future results, performance or achievements implied by such forward-looking statements. Such risks and uncertainties include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses; engaging in activities which currently are illegal under United States federal law and the uncertainty of existing protection from United States federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including United States state-law legalization, particularly in Florida, due to inconsistent public opinion, perception of the medical-use and adult-use cannabis industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; reliance on management; and the effect of capital market conditions and other factors on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Although it may voluntarily do so from time to time, the Company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Unless otherwise noted, the forecasted industry and market data contained herein are based upon management estimates and industry and market publications and surveys. The information from industry and market publications has been obtained from sources believed to be reliable, but there can be no assurance as to the accuracy or completeness of the included information. The Company has not independently verified any of the data from third-party sources, nor has the Company ascertained the underlying economic assumptions relied upon therein. While such information is believed to be reliable for the purposes used herein, the Company makes no representation or warranty with respect to the accuracy of such information. PLEASE NOTE: MARIJUANA IS ILLEGAL UNDER U.S. FEDERAL LAW, INCLUDING ITS CONSUMPTION, POSSESSION, CULTIVATION, DISTRIBUTION, MANUFACTURING, DISPENSING, AND POSSESSION WITH INTENT TO DISTRIBUTE. Forward-looking statements made in this document are made only as of the date of their initial publication, and the Company undertakes no obligation to publicly update any of these forward-looking statements as actual events unfold. 2#3www.trulieve.com Management's Use of Non-GAAP Financial Measures In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP financial measures, including adjusted net income, adjusted earnings per share, adjusted EBITDA, and free cash flow. Our management uses these non-GAAP financial measures in conjunction with GAAP financial measures to evaluate our operating results and financial performance. We believe these measures are useful to investors as they are widely used measures of performance and can facilitate comparison to other companies. These non-GAAP financial measures are not, and should not be considered as measures of liquidity. These non-GAAP financial measures have limitations as analytical tools in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Because of these limitations, these non-GAAP financial measures should be considered along with GAAP financial performance measures. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures. A reconciliation of the non-GAAP financial measures to such GAAP measures can be found below. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. 3#4www.trulieve.com Agenda • Third Quarter 2023 Financial and Operational Highlights Retail Highlights Recent Developments Tax Position • 2023 Objectives • Financial Targets Financial Highlights 4#5www.trulieve.com Third Quarter 2023 Financial and Operational Highlights* . Revenue $275 million, with 96% revenue from retail sales . GAAP gross profit of $143 million and 52% gross margin, improved by 2% sequentially SG&A expenses of $94 million, lowered by $2 million sequentially Net loss of $25 million Adjusted net loss of $15 million excludes non-recurring charges, disposals and discontinued operations EBITDA of $74 million or 27% of revenue and Adjusted EBITDA of $78 million or 28% of revenue Cash flow from operations of $93 million Free cash flow of $87 million Generated cash flow from operations excluding tax payments of $184 million year to date Purchased $57 million face value senior secured 2026 notes for $47.6 million, which represents a 16.5% discount to par, plus accrued interest Opened dispensaries in Pace and Sanford, FL, Evans and Pooler, GA, and Columbus, OH Relocated one dispensary in Kissimmee, FL * Adjusted net loss, adjusted EBITDA, and free cash flow are Non-GAAP financial measures. See slides 14-16 for reconciliation to GAAP for all Non-GAAP financial measures. Numbers may not sum perfectly due to rounding. 5#6www.trulieve.com Retail Highlights Revenue $275 million Retail revenue of $263 million o Customer retention 65% companywide О Customer retention 74% medical only • Sold over 11 million branded products • Maryland recreational sales launched . July 1, 2023 。 235% increase in traffic O О 175% increase in sales per store Exited the quarter with 32% of retail locations outside of the state of Florida URITY TIMELESS Trulieve Trulieve T TRULIEVE NOW OPEN. Cultivate Together. 6#7www.trulieve.com Recent Developments . Announced full redemption of $130 million of senior secured notes due June 18, 2024 with redemption date of December 1, 2023 Filed amended federal tax returns for 2019, 2020, and 2021 claiming a $143 million refund from taxes paid • On November 8, 2023, the Florida Supreme Court heard oral arguments regarding the Smart and Safe Florida ballot initiative for adult use, with ruling expected prior to April 2024 . . Launched distribution through independent pharmacies in Georgia Added retail locations in Apollo Beach and Marianna, FL and relocated one dispensary in Melbourne, FL Currently operate 190 retail dispensaries and over 4 million square feet of cultivation and processing capacity in the United States 7#8www.trulieve.com Tax Position . In October, Trulieve filed amended federal tax returns for 2019, 2020, and 2021 claiming a $143 million refund from taxes paid Trulieve intends to make tax payments as a customary U.S. taxpayer without tax liabilities associated with 280E of the tax code • Trulieve has already made estimated tax payments for 2022 and 1H:2023 including ordinary tax and 280E tax liabilities • Cash taxes paid year to date through September total $113 million . Trulieve did not pay cash taxes in Q3:23 due to the deferral until February 2024 for businesses impacted by Hurricane Idalia 8#9www.trulieve.com 2023 Objectives Cash Preservation . Successfully reduced operating expenses through business optimization initiatives • Balanced promotional activity and inventory reduction measures to preserve margin • Exited underperforming assets and markets Cash Generation • Streamlined operations to focus on cash generation • Reduced inventory across multiple markets, generating $47 million in cash Ramped new lower cost 750K indoor production facility Investments in the Future: • Smart and Safe Florida Campaign • New market and retail development Technology platforms for integrated commerce environment • Consideration of strategic M&A opportunities 9#10Financials#11www.trulieve.com Financial Targets Financial Targets: • Anticipate fourth quarter revenue will be down low single digits compared to the third quarter 。 Contribution from Ohio VIE may be excluded 。 Q4 revenue influenced by promotional activity and consumer behavior Operating cash flow in 2023 will exceed target of $100 million • Q4 capital expenditures expected to be approximately $10 million . Expect free cash flow of at least $70 million in 2023 . Add 15 - 20 new dispensaries, relocate up to 6 Financial Position: $199 million in cash as of September 30, 2023 11#12www.trulieve.com Financial Highlights* INCOME STATEMENT HIGHLIGHTS (USD millions, except per share data) Q3:23 Q2:23 Q1:23 Q4:22 Q3:22 Q2:22 Q1:22 2022 Revenue 275.2 281.8 285.2 298.5 295.4 313.8 310.6 1218.2 Gross Profit 142.9 Gross Margin Adjusted Gross Profit Adjusted Gross Margin SG&A SG&A as % Revenue Adjusted SG&A Adjusted SG&A as % Revenue Depreciation and Amortization Net (Loss) Income** Net (Loss) Income Continuing Operations Adjusted Net (Loss) Income 27.0 26.1 141.6 150.2 51.9% 50.3% 52.6% 143.1 143.3 150.2 52.0% 50.9% 52.7% 93.9 96.0 100.0 34.1% 34.1% 35.1% 84.6 81.1 86.7 30.7% 28.8% 30.4% 29.6 30.6% 157.1 168.7 52.6% 57.1% 58.4% 161.1 172.5 183.2 184.6 54.0% 58.4% 58.4% 59.5% 122.8 111.9 107.5 104.9 41.1% 37.9% 34.2% 94.0 90.4 31.5% 183.4 179.9 689.0 57.9% 56.6% 701.4 57.6% 447.0 33.8% 36.7% 90.5 93.5 368.4 28.8% 30.1% 30.2% 29.8 29.5 29.4 27.8 116.4 (25.4) (403.8) (64.1) (77.0) (114.6) (22.5) (32.0) (246.1) EPS** EPS Continuing Operations Adjusted EPS Adjusted EBITDA Adjusted EBITDA Margin (22.9) (342.1) (34.3) (14.7) (14.7) (17.8) (0.13) (2.14) (0.34) (0.41) (0.12) (1.80) (0.18) (0.08) (0.08) (0.09) 77.7 78.7 78.1 28.2% 27.9% 27.4% (64.4) (72.6) (18.7) (27.0) (182.8) (34.2) 7.9 2.8 4.7 (18.9) (0.61) (0.12) (0.17) (1.31) (0.33) (0.38) (0.09) (0.14) (0.9) (0.18) 0.04 0.01 0.03 (0.10) 82.4 99.6 111.0 27.6% 33.7% 35.4% 33.8% 105.0 397.1 32.6% *Adjusted net income, adjusted EPS, adjusted EBITDA and adjusted EBITDA Margin are Non-GAAP financial measures. See slides 14- 16 for reconciliation to GAAP for all Non-GAAP financial measures. **Includes discontinued operations. 12#13www.trulieve.com Financial Highlights SHARE COUNT ESTIMATE (millions as of September 30, 2023 on as if converted basis) Subordinate Voting Shares Multiple Voting Shares* Total Shares Outstanding * converted at 100 subordinate shares per 1 multiple voting share Employee Stock Options/RSUS excludes 2.2 million unexercisable options excludes 3.286 million nonvested RSUs Pro Forma Estimated Shares 159.8 0.3 186.0 5.3 191.3 13#14www.trulieve.com Reconciliation of Non-GAAP Financial Measures For the Three Months Ended For the Nine Months Ended September 30, September 30, September 30, June 30, 2023 (Amounts expressed in millions of United States dollars) 2023 2022 2023 Net Loss GAAP Add (Deduct) Impact of: Interest Expense Provision For Income Taxes Depreciation and Amortization $ (25.4) $ (114.6) $ (403.8) $ (493.4) September 30, 2022 (169.0) $ 20.8 17.7 $ 18.9 SA $ 60.9 $ 52.2 $ 36.6 28.4 $ 34.0 $ 105.9 $ 116.8 $ Depreciation in COGS EBITDA $ EA EA Impairment of Goodwill $ $ --- Impairments and Disposals of Long-lived Assets, Net $ (1.2) Results of Discontinued Operations $ 2.9 Acquisition and Transaction Costs $ Integration and Transition Costs 27.0 14.6 73.7 SA 29.5 $ 26.1 $ 82.6 GA 86.6 $ SA 13.2 $ 16.0 $ 42.8 $ EA 34.9 (25.8) $ (308.9) $ (201.1) $ 121.5 SAS SASSA --- $ 54.6 SASA $ 307.6 $ 3.3 SASA $ 307.6 $ 5.5 42.4 $ 63.9 SA SA --- $ Other Non-Recurring Costs Share-Based Compensation SA Legislative Campaign Contributions Inventory Step Up Fair Value $ 8.5 --- 4.5 0.5 SS 7.0 $ 6.7 SASA --- $ 5.7 SASASA $ 97.9 SASSA --- 76.2 $ 53.2 $ --- $ 16.1 SASA 17.2 17.1 SA EA 1.9 4.3 --- S --- $ EA 11.6 SA 10.0 $ --- $ 0.5 8.6 EA $ SA 7.4 SA 14.6 Covid Related Expenses Other (Income) Expense, net Fair Value of Derivative Liabilities - Warrants Results of Entities Not Legally Controlled Adjusted EBITDA Non-GAAP $ EA 19.6 EA 10.0 $ --- SA $ EA 1.0 $ $ 0.2 $ $ SA $ 0.8 $ (11.2) (0.4) $ (2.0) $ (18.1) SA $ (0.4) $ (0.9) SASA $ $ (0.3) $ $ SASA Ꭿ (3.0) (2.6) (1.9) $ 77.7 99.6 $ 78.7 $ 234.6 $ 315.5 14#15www.trulieve.com Reconciliation of Non-GAAP Financial Measures For the Three Months Ended For the Nine Months Ended (Amounts expressed in millions of United States dollars) September 30, 2023 September 30, September 30, June 30, 2023 2022 2023 Net Loss GAAP Add (Deduct) Impact of: Impairment of Goodwill Inventory Step Up Fair Value (25.4) $ (114.6) $ (403.8) (493.4) $ September 30, 2022 (169.0) Fair Value of Derivative Liabilities - Warrants Transaction, Acquisition, and Integration Costs Legislative Campaign Contributions Covid Related Expenses Impairments and Disposals of Long-lived Assets, Net Results of Discontinued Operations Adjusted Net (Loss) Income Non-GAAP SSSSSSSSS --- --- $ 8.5 0.5 --- $ (1.2) $ 2.9 $ (14.7) SSSSSSSSS $ 307.6 (0.4) $ $ $ 15.5 $ 10.0 $ 0.2 $ $ $ 54.6 42.4 $ 7.9 SSSSSSASA --- $ 5.7 $ 8.6 --- $ 3.3 SSSSSSCA $ 307.6 (0.3) --- $ 16.1 19.6 --- $ 5.5 $ 63.9 (14.7) $ 97.9 (47.0) SSSSSSSS $ (2.6) 1.0 $ 45.9 10.0 0.8 $ 76.2 $ 53.2 $ 15.4 For the Three Months Ended September 30, (Amounts expressed are per share) Loss Per Share GAAP Add (Deduct) Impact of: Impairment of Goodwill 2023 September 30, 2022 June 30, 2023 For the Nine Months Ended September 30, September 30, 2023 2022 $ (0.13) $ (0.61) $ (2.14) $ (2.61) $ (0.90) GA --- $ $ 1.63 $ 1.63 --- Fair Value of Derivative Liabilities - Warrants Inventory Step Up Fair Value Transaction, Acquisition, and Integration Costs $ SASSA EA (0.00) $ --- --- $ 0.04 $ SASA $ --- 0.08 $ 0.03 SASSA (0.00) Ꭿ (0.01) 111 $ 0.01 $ 0.09 $ FA 0.24 Legislative Campaign Contributions Covid Related Expenses Impairments and Disposals of Long-lived Assets, Net Results of Discontinued Operations Adjusted Earnings Per Share Non-GAAP SSSSS $ 0.00 $ --- $ SASA 0.05 $ 0.05 0.00 $ EA --- $ (0.01) 0.02 (0.08) SASSA $ 0.29 $ 0.02 $ 0.23 $ 0.34 $ 0.04 $ (0.08) SSSSS $ 0.10 --- SASA $ 0.05 $ 0.00 $ 0.03 $ 0.52 (0.25) SASASA $ 0.41 $ 0.28 0.08 15#16www.trulieve.com Reconciliation of Non-GAAP Financial Measures (Amounts expressed in millions of United States dollars) Cash Flow From Operating Activities Payments for Property and Equipment Free Cash Flow For the Three Months Ended For the Nine Months Ended 2023 $ 93.4 $ (6.3) 87.2 September 30, September 30, 2022 $ (21.6) (37.6) SSSA September 30, September 30, June 30, 2023 2023 2022 $ (23.5) $ 70.4 $ (31.9) $ $ (59.2) SSA $ (11.0) $ (31.0) $ (130.4) $ (34.5) $ 39.4 (162.3) 16#17www.trulieve.com Regional Hubs: Cultivation, Processing, Retail Capacity SOUTHWEST 21 stores >0.25M ft² cultivation & processing AZ CO 190 Stores As of November 9, 2023 All stores owned, operated, or affiliated >4 M ft² Cultivation & Processing As of September 30, 2023 OH GA FL NORTHEAST 35 stores >0.45M ft² cultivation & processing CT PA MD SOUTHEAST 134 stores >3.3M ft² cultivation & processing 17#18www.trulieve.com House of Brands PREMIUM VALUE MID Trulieve Brands Collection AVENUE™ A Alchemy MOMENTA Roll One ALL THE WEED YOU NEED Partner Brands BLACK TUNA DeJisioso Muse It makes you feel like dancing! CANNABIS MODERN™ FLOWER Sweet TALK colors Loveli BELLAMY BROTHERS CONREGED Allieflat CANNABIS CO. Seed Junky BLUE RIVER™ LOVE'S OVEN El Blunto THE WORLD'S FINEST CANNABIS EXPERIENCE SUNSHINE CANNABIS Khalifa Kush binske M 0 $ R ם G 18#19Thank You CSE: TRUL OTCQX: TCNNF [f] @Trulieve/@Trulieve_IR [email protected]